Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Durango. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Durango at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This study will assess corneal endothelial cells in participants with nAMD treated with PDS refilled every 24 weeks (Q24W).
Sponsor: Genentech, Inc.
Check if you qualify for this macular degeneration clinical trial in Durango, CO
If you're searching for macular degeneration treatment options in Durango, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Durango research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.